Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Taysha Gene Therapies (TSHA) Profit After Tax: 2020-2024

Historic Profit After Tax for Taysha Gene Therapies (TSHA) over the last 5 years, with Dec 2024 value amounting to -$89.3 million.

  • Taysha Gene Therapies' Profit After Tax fell 28.24% to -$32.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$99.9 million, marking a year-over-year decrease of 338.82%. This contributed to the annual value of -$89.3 million for FY2024, which is 19.96% up from last year.
  • As of FY2024, Taysha Gene Therapies' Profit After Tax stood at -$89.3 million, which was up 19.96% from -$111.6 million recorded in FY2023.
  • In the past 5 years, Taysha Gene Therapies' Profit After Tax registered a high of -$60.0 million during FY2020, and its lowest value of -$174.5 million during FY2021.
  • Its 3-year average for Profit After Tax is -$122.3 million, with a median of -$111.6 million in 2023.
  • As far as peak fluctuations go, Taysha Gene Therapies' Profit After Tax plummeted by 190.82% in 2021, and later surged by 32.80% in 2023.
  • Taysha Gene Therapies' Profit After Tax (Yearly) stood at -$60.0 million in 2020, then slumped by 190.82% to -$174.5 million in 2021, then rose by 4.88% to -$166.0 million in 2022, then surged by 32.80% to -$111.6 million in 2023, then rose by 19.96% to -$89.3 million in 2024.